Cor­rect­ed: Emer­gent sells Bal­ti­more fa­cil­i­ty for $30M

Emer­gent BioSo­lu­tions is sell­ing off a Bal­ti­more man­u­fac­tur­ing site for $30 mil­lion to Bo­ra Phar­ma­ceu­ti­cals.

“The de­ci­sion to sell our Cam­den man­u­fac­tur­ing fa­cil­i­ty is aligned …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.